(19)
(11) EP 4 568 972 A1

(12)

(43) Date of publication:
18.06.2025 Bulletin 2025/25

(21) Application number: 23753891.3

(22) Date of filing: 07.08.2023
(51) International Patent Classification (IPC): 
C07D 498/04(2006.01)
A61P 11/00(2006.01)
C07D 519/00(2006.01)
A61K 31/5365(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 519/00; C07D 498/04; A61P 11/00
(86) International application number:
PCT/EP2023/071758
(87) International publication number:
WO 2024/033277 (15.02.2024 Gazette 2024/07)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 08.08.2022 EP 22189168
31.05.2023 EP 23176294

(71) Applicant: F. Hoffmann-La Roche AG
4070 Basel (CH)

(72) Inventors:
  • BENZ, Joerg
    4070 Basel (CH)
  • GIROUD, Maude
    4070 Basel (CH)
  • GRETHER, Uwe Michael
    4070 Basel (CH)
  • KUHN, Bernd
    4070 Basel (CH)
  • LELKE, Alina
    4070 Basel (CH)
  • O'HARA, Fionn Susannah
    4070 Basel (CH)
  • RITTER, Martin
    4070 Basel (CH)
  • ROMBACH, Didier
    4070 Basel (CH)
  • SCHMID, Philipp Claudio
    4070 Basel (CH)
  • WITTWER, Matthias Beat
    4070 Basel (CH)

(74) Representative: Neuhaus, Christian Michel 
F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel
4070 Basel (CH)

   


(54) NEW HETEROCYCLIC COMPOUNDS